Filippo Beleggia (F Beleggia)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Hodgkin Lymphoma

Palliative Care

Brain Metastases

Small Cell Lung Cancer

Top Venues

Cell death & disease

Nature communications

Blood cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

L Valdez Capuccino, T Kleitke, B Szokol, L Svajda, Fernando Martín Silva, F Bonechi, M Krekó, S Azami, Antonella Montinaro, Y Wang, V Nikolov, Laura Kaiser, D Bonasera, J Saggau, T Scholz, A Schmitt, Filippo Beleggia, H C Reinhardt, J George, Gianmaria Liccardi, H Walczak, J Tóvári, Johannes Brägelmann, J Montero, M L Sos, L Őrfi, Nieves Peltzer
CDK9 inhibition as an effective therapy for small cell lung cancer. Cell death & disease 15 (5) (2024)
L Valdez Capuccino, T Kleitke, B Szokol, L Svajda, Fernando Martín Silva, F Bonechi, M Krekó, S Azami, Antonella Montinaro, Y Wang, V Nikolov, Laura Kaiser, D Bonasera, J Saggau, T Scholz, A Schmitt, Filippo Beleggia, H C Reinhardt, J George, Gianmaria Liccardi, H Walczak, J Tóvári, Johannes Brägelmann, J Montero, M L Sos, L Őrfi, Nieves Peltzer
CDK9 inhibition as an effective therapy for small cell lung cancer. Cell death & disease 15 (5) (2024)
L Valdez Capuccino, T Kleitke, B Szokol, L Svajda, Fernando Martín Silva, F Bonechi, M Krekó, S Azami, Antonella Montinaro, Y Wang, V Nikolov, Laura Kaiser, D Bonasera, J Saggau, T Scholz, A Schmitt, Filippo Beleggia, H C Reinhardt, J George, Gianmaria Liccardi, H Walczak, J Tóvári, Johannes Brägelmann, J Montero, M L Sos, L Őrfi, Nieves Peltzer
CDK9 inhibition as an effective therapy for small cell lung cancer. Cell death & disease 15 (5) (2024)
L Valdez Capuccino, T Kleitke, B Szokol, L Svajda, Fernando Martín Silva, F Bonechi, M Krekó, S Azami, Antonella Montinaro, Y Wang, V Nikolov, Laura Kaiser, D Bonasera, J Saggau, T Scholz, A Schmitt, Filippo Beleggia, H C Reinhardt, J George, Gianmaria Liccardi, H Walczak, J Tóvári, Johannes Brägelmann, J Montero, M L Sos, L Őrfi, Nieves Peltzer
CDK9 inhibition as an effective therapy for small cell lung cancer. Cell death & disease 15 (5) (2024)
Ruth Flumann, Julia Hansen, Benedikt W Pelzer, Pascal Nieper, Tim Lohmann, Ilmars Kisis, Tobias Riet, Viktoria Kohlhas, Phuong-Hien Nguyen, Martin Peifer, Nima Abedpour, Graziella Bosco, Roman K Thomas, Moritz Kochanek, Jacqueline Knufer, Lorenz Jonigkeit, Filippo Beleggia, Alessandra M E Holzem, Reinhard Buttner, Philipp Lohneis, Jorn Meinel, Monika Ortmann, Thorsten Persigehl, Michael Hallek, Dinis Pedro Calado, Markus Chmielewski, Sebastian Klein, Joachim R Göthert, Bjoern Chapuy, Elena I Rugarli, Frank Thomas Wunderlich, Bastian von Tresckow, Ron D Jachimowicz, Ari M Melnick, Hans Christian Reinhardt, Gero Knittel
Distinct genetically-determined origins of Myd88/Bcl2-driven aggressive lymphoma rationalize targeted therapeutic intervention strategies. Blood cancer discovery (2022)
Christina M Bebber, Emily S Thomas, Jenny Stroh, Zhiyi Chen, Ariadne Androulidaki, Anna Schmitt, Michaela N Höhne, Lukas Stüker, Cleidson de Pádua Alves, Armin Khonsari, Marcel A Dammert, Fatma Parmaksiz, Hannah L Tumbrink, Filippo Beleggia, Martin L Sos, Jan Riemer, Julie George, Susanne Brodesser, Roman K Thomas, H Christian Reinhardt, Silvia von Karstedt
Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypes. Nature communications 12 (1) (2021)